We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+1.29%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$8.89B
AUM Growth
-$1.49B
Cap. Flow
-$1.55B
Cap. Flow %
-17.42%
Top 10 Hldgs %
47.67%
Holding
1,012
New
106
Increased
478
Reduced
302
Closed
124

Top Buys

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$37.3M
2
MMP
Magellan Midstream Partners, L.P.
MMP
+$31.1M
3
BMY icon
Bristol-Myers Squibb
BMY
+$27.8M
4
NEM icon
Newmont
NEM
+$27.4M
5
CMI icon
Cummins
CMI
+$24.3M

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$430M
2
JPM icon
JPMorgan Chase
JPM
+$168M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$132M
4
YUM icon
Yum! Brands
YUM
+$105M
5
PFE icon
Pfizer
PFE
+$92.8M

Sector Composition

Rank Sector Weight
1 Energy 59.33%
2 Technology 6.01%
3 Healthcare 4.63%
4 Consumer Discretionary 3.72%
5 Financials 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOGO icon
926
Gogo Inc
GOGO
$515M
– –
-24,483
Closed -$424K
HUBB icon
927
Hubbell
HUBB
$25.7B
– –
-1,379
Closed -$249K
INO icon
928
Inovio Pharmaceuticals
INO
$79.8M
– –
-21,486
Closed -$1.85M
IRON icon
929
Disc Medicine
IRON
$2.83B
– –
-1,761
Closed -$213K
JNPR
930
DELISTED
Juniper Networks
JNPR
– –
-830,422
Closed -$22.9M
K
931
DELISTED
Kellanova
K
– –
-392,315
Closed -$23.5M
KN icon
932
Knowles
KN
$3.22B
– –
-17,653
Closed -$331K
KNSA icon
933
Kiniksa Pharmaceuticals
KNSA
$4.83B
– –
-83,983
Closed -$957K
KOF icon
934
Coca-Cola Femsa
KOF
$21.6B
– –
-9,283
Closed -$522K
KRRO icon
935
Korro Bio
KRRO
$153M
– –
-844
Closed -$298K
KW
936
DELISTED
Kennedy-Wilson Holdings
KW
– –
-13,735
Closed -$287K
LEGN icon
937
Legend Biotech
LEGN
$4.3B
– –
-177,274
Closed -$8.96M
MAC icon
938
Macerich
MAC
$7.32B
– –
-42,475
Closed -$710K
MDGL icon
939
Madrigal Pharmaceuticals
MDGL
$12.6B
– –
-20,338
Closed -$1.62M
MDT icon
940
Medtronic
MDT
$107B
– –
-3,458
Closed -$433K
MGTX icon
941
MeiraGTx Holdings
MGTX
$1.09B
– –
-54,308
Closed -$716K
MIRM icon
942
Mirum Pharmaceuticals
MIRM
$6.89B
– –
-37,401
Closed -$745K
MRKR icon
943
Marker Therapeutics
MRKR
$20.3M
– –
-10,183
Closed -$172K
NEO icon
944
NeoGenomics
NEO
$1.81B
– –
-5,954
Closed -$287K
NSA
945
DELISTED
National Storage Affiliates Trust
NSA
– –
-12,391
Closed -$654K
NWS icon
946
News Corp Class B
NWS
$16.4B
– –
-74,186
Closed -$1.72M
NYT icon
947
New York Times
NYT
$11.6B
– –
-6,331
Closed -$312K
OCFC icon
948
OceanFirst Financial
OCFC
$1.7B
– –
-10,031
Closed -$215K
OLP
949
One Liberty Properties
OLP
$548M
– –
-23,479
Closed -$716K
OPI
950
DELISTED
Office Properties Income Trust
OPI
– –
-28,242
Closed -$715K
36 37
38
39 40

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, ALPS Advisors held 1,012 positions worth $8.89B, down 14% from $10.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors withdrew a net $1.55B in Q4 2021, closing 124 positions and reducing 302 holdings. Its most notable exit was Berkshire Hathaway Class A, an estimated $430M position sold in full.

By sector, the portfolio is most concentrated in Energy at 59% of assets, up from 51% a quarter earlier, followed by Technology and Healthcare.

Against the trend, ALPS Advisors opened a new position in Bristol-Myers Squibb worth $29.6M.

  • ALPS Advisors's largest Q4 2021 buy was Bristol-Myers Squibb: 474,459 shares worth $29.6M.
  • ALPS Advisors added most to Energy Transfer Partners in Q4 2021, an estimated $37.3M increase.
  • ALPS Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $168M.
  • ALPS Advisors fully exited Berkshire Hathaway Class A in Q4 2021, selling an estimated $430M.
  • ALPS Advisors's ten largest holdings make up 48% of its $8.89B portfolio in Q4 2021.
  • ALPS Advisors opened 106 new positions and closed 124 in Q4 2021.
  • ALPS Advisors's portfolio value fell 14% quarter-over-quarter to $8.89B.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.